Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
04:00:00 17/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.690 USD | +0.60% |
|
+11.18% | -41.32% |
| Market Cap | 5.66M 5.05M 4.67M 4.25M 8M 538M 8.13M 56.22M 22.06M 281M 21.26M 20.8M 894M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 128K 114K 105K 95.74K 180K 12.11M 183K 1.27M 497K 6.32M 479K 468K 20.14M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +0.60% | ||
| 1 week | +11.18% | ||
| Current month | +3.05% | ||
| 1 month | -11.05% | ||
| 3 months | -26.84% | ||
| 6 months | -45.48% | ||
| Current year | -41.32% |
| 1 week | 1.5 |  | 1.98 |
| 1 month | 1.04 | | 2.02 |
| Current year | 1.04 | | 3.8 |
| 1 year | 1.04 | | 10.84 |
| 3 years | 1.04 | | 435 |
| 5 years | 1.04 | | 4,065 |
| 10 years | 1.04 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/7/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/7/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.60% | +11.18% | -77.91% | -99.45% | 5.66M | |
| -6.60% | -8.56% | +49.38% | +63.51% | 65B | |
| +0.03% | +5.56% | +9.10% | +69.05% | 51.2B | |
| -4.09% | -0.11% | +2.22% | +53.15% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +34.12% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +115.13% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +454.22% | 38.14B | |
| +6.53% | +8.02% | +16.40% | +53.41% | 33.24B | |
| -0.90% | -10.49% | +37.09% | -3.70% | 25.2B | |
| -1.07% | +2.33% | +19.43% | +9.98% | 22.5B | |
| Average | -1.43% | +0.80% | +33.18% | +74.94% | 37.24B | |
| Weighted average by Cap. | -2.20% | -0.50% | +44.25% | +96.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.57M -9.77M -8.89M -16.74M -1.13B -17.02M -118M -46.15M -587M -44.47M -43.52M -1.87B | -13.56M -12.1M -11.18M -10.18M -19.16M -1.29B -19.48M -135M -52.82M -672M -50.9M -49.81M -2.14B |
| Net Debt | -1.12M -997K -922K -839K -1.58M -106M -1.61M -11.09M -4.35M -55.36M -4.19M -4.11M -176M | -5.54M -4.94M -4.56M -4.16M -7.82M -526M -7.95M -54.95M -21.56M -274M -20.78M -20.34M -874M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$1.690 | +0.60% | 22,058 |
| 15/10/26 | US$1.680 | +4.02% | 31,149 |
| 14/10/26 | US$1.615 | -8.76% | 46,370 |
| 13/10/26 | US$1.770 | -6.84% | 69,180 |
| 12/10/26 | US$1.900 | +25.00% | 441,028 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
